Jorge Montesinos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jorge Montesinos has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Estela Area-Gomez
Centro de Investigaciones Biológicas Margarita Salas (CIBERNED), CSIC, Madrid, Spain. Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
8 shared publications Delfina Larrea
Columbia University
3 shared publications- Rishi R. Agrawal
Institute of Human Nutrition, Columbia University Irving Medical Center, New York, USA
3 shared publications - Alexander Galkin
Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA
2 shared publications Anna Fernàndez-Bernal
Universitat de Lleida
2 shared publications- Anna Stepanova
Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in Research Square
A sphingomyelin-cholesterol complex regulates TLR4 activation in microglia
Microglial activation in response to lipopolysaccharide (LPS) requires Toll-like receptor 4 (TLR4) redistribution into cholesterol- and sphingolipid-rich membrane domains, yet the lipid determinants of this process remain unclear. Here, we identify cholesterol accessibility as a key driver of TLR4-dependent microglial activation. We show that LPS increases cholesterol uptake and mobilization, whereas inhibition of intracellular cholesterol trafficking or the plasma membrane-to-ER cholesterol transporter Aster attenuates inflammatory responses. Scavenger receptor class B type 1 (SR-B1) mediates LPS-induced cholesterol uptake, and its inhibition suppresses TLR4 signaling, receptor recruitment to detergent-resistant membrane domains, and TLR4 endocytosis without altering bulk cellular cholesterol. Instead, SR-B1 inhibition remodels the sphingolipidome and expands the sphingomyelin-associated cholesterol pool, as detected by OlyA, while LPS promotes remodeling of this pool and increases accessible cholesterol detected by D4H. Manipulation of sphingomyelin-cholesterol interactions alters membrane properties and TLR4 trafficking, while stabilization of these complexes suppresses inflammatory activation. In vivo, LPS induces remodeling of sphingomyelin-associated cholesterol in microglia, whereas Alzheimer’s disease-related ApoE4/Trem2 R47H microglia show impaired cholesterol-pool remodeling and enhanced inflammatory responses. Together, these findings establish sphingolipid-dependent cholesterol accessibility as a key regulatory layer controlling TLR4 organization and microglial inflammatory activation, positioning SR-B1 as an upstream regulator of this lipid-signaling axis.
- 3 November 2026
- Published by Springer Nature in Research Square
Open AccessA sphingomyelin-cholesterol complex regulates TLR4 activation in microglia
Microglial activation in response to lipopolysaccharide (LPS) requires Toll-like receptor 4 (TLR4) redistribution into cholesterol- and sphingolipid-rich membrane domains, yet the lipid determinants of this process remain unclear. Here, we identify cholesterol accessibility as a key driver of TLR4-dependent microglial activation. We show that LPS increases cholesterol uptake and mobilization, whereas inhibition of intracellular cholesterol trafficking or the plasma membrane-to-ER cholesterol transporter Aster attenuates inflammatory responses. Scavenger receptor class B type 1 (SR-B1) mediates LPS-induced cholesterol uptake, and its inhibition suppresses TLR4 signaling, receptor recruitment to detergent-resistant membrane domains, and TLR4 endocytosis without altering bulk cellular cholesterol. Instead, SR-B1 inhibition remodels the sphingolipidome and expands the sphingomyelin-associated cholesterol pool, as detected by OlyA, while LPS promotes remodeling of this pool and increases accessible cholesterol detected by D4H. Manipulation of sphingomyelin-cholesterol interactions alters membrane properties and TLR4 trafficking, while stabilization of these complexes suppresses inflammatory activation. In vivo, LPS induces remodeling of sphingomyelin-associated cholesterol in microglia, whereas Alzheimer’s disease-related ApoE4/Trem2 R47H microglia show impaired cholesterol-pool remodeling and enhanced inflammatory responses. Together, these findings establish sphingolipid-dependent cholesterol accessibility as a key regulatory layer controlling TLR4 organization and microglial inflammatory activation, positioning SR-B1 as an upstream regulator of this lipid-signaling axis.
- Open Access
- 5 October 2026
- Published by Elsevier in SSRN Electronic Journal
Upregulation of MAM by C99 Disrupts ACSL4 Activity and Phospholipid
The structure and function of cellular and intracellular membranes are critically governed by the fatty acid (FA) composition of phospholipids (PLs), which are dynamically regulated by a network of enzymes that fine-tune lipid species according to cellular demands.Membrane lipid abnormalities are a pervasive feature of Alzheimer’s disease (AD), but the origin of these alterations and their link to the aberrant amyloid precursor protein (APP) metabolism chartacteristic of AD remains unknown. Here, we identify mitochondria-associated ER membranes (MAM) as a spatial regulator linking APP processing to membrane lipid remodeling. Through integrated biochemical, proteomic, and lipidomic analyses in both cellular and animal models, we demonstrate that the formation of MAM modulates the activity of the acyl-CoA synthetase long-chain family member 4 (ACSL4), an enzyme that channels polyunsaturated fatty acids (PUFAs) into phosphatidylcholine (PC) via the Lands cycleThese findings reveal a previously unrecognized link whereby the accumulation of the 99-amino-acid C-terminal region of APP (C99) remodels MAM to spatially control ACSL4-dependent lipid flux, thereby providing a mechanistic link between APP dysregulation and membrane lipid abnormalities in AD. More broadly, they establish organelle contact sites as critical regulators of membrane lipid composition and suggest that persistent MAM remodeling may contribute to cellular dysfunction by disrupting membrane homeostasis.
- 5 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessUpregulation of MAM by C99 Disrupts ACSL4 Activity and Phospholipid
The structure and function of cellular and intracellular membranes are critically governed by the fatty acid (FA) composition of phospholipids (PLs), which are dynamically regulated by a network of enzymes that fine-tune lipid species according to cellular demands.Membrane lipid abnormalities are a pervasive feature of Alzheimer’s disease (AD), but the origin of these alterations and their link to the aberrant amyloid precursor protein (APP) metabolism chartacteristic of AD remains unknown. Here, we identify mitochondria-associated ER membranes (MAM) as a spatial regulator linking APP processing to membrane lipid remodeling. Through integrated biochemical, proteomic, and lipidomic analyses in both cellular and animal models, we demonstrate that the formation of MAM modulates the activity of the acyl-CoA synthetase long-chain family member 4 (ACSL4), an enzyme that channels polyunsaturated fatty acids (PUFAs) into phosphatidylcholine (PC) via the Lands cycleThese findings reveal a previously unrecognized link whereby the accumulation of the 99-amino-acid C-terminal region of APP (C99) remodels MAM to spatially control ACSL4-dependent lipid flux, thereby providing a mechanistic link between APP dysregulation and membrane lipid abnormalities in AD. More broadly, they establish organelle contact sites as critical regulators of membrane lipid composition and suggest that persistent MAM remodeling may contribute to cellular dysfunction by disrupting membrane homeostasis.
- Open Access
A sphingomyelin-cholesterol complex regulates TLR4 activation in microglia
Microglial activation in response to lipopolysaccharide (LPS) requires Toll-like receptor 4 (TLR4) redistribution into cholesterol- and sphingolipid-rich membrane domains, yet the lipid determinants of this process remain unclear. Here, we identify cholesterol accessibility as a key driver of TLR4-dependent microglial activation. We show that LPS increases cholesterol uptake and mobilization, whereas inhibition of intracellular cholesterol trafficking or the plasma membrane-to-ER cholesterol transporter Aster attenuates inflammatory responses. Scavenger receptor class B type 1 (SR-B1) mediates LPS-induced cholesterol uptake, and its inhibition suppresses TLR4 signaling, receptor recruitment to detergent-resistant membrane domains, and TLR4 endocytosis without altering bulk cellular cholesterol. Instead, SR-B1 inhibition remodels the sphingolipidome and expands the sphingomyelin-associated cholesterol pool, as detected by OlyA, while LPS promotes remodeling of this pool and increases accessible cholesterol detected by D4H. Manipulation of sphingomyelin-cholesterol interactions alters membrane properties and TLR4 trafficking, while stabilization of these complexes suppresses inflammatory activation. In vivo, LPS induces remodeling of sphingomyelin-associated cholesterol in microglia, whereas Alzheimer's disease-related ApoE4/Trem2R47H microglia show impaired cholesterol-pool remodeling and enhanced inflammatory responses. Together, these findings establish sphingolipid-dependent cholesterol accessibility as a key regulatory layer controlling TLR4 organization and microglial inflammatory activation, positioning SR-B1 as an upstream regulator of this lipid-signaling axis.
Open AccessA sphingomyelin-cholesterol complex regulates TLR4 activation in microglia
Microglial activation in response to lipopolysaccharide (LPS) requires Toll-like receptor 4 (TLR4) redistribution into cholesterol- and sphingolipid-rich membrane domains, yet the lipid determinants of this process remain unclear. Here, we identify cholesterol accessibility as a key driver of TLR4-dependent microglial activation. We show that LPS increases cholesterol uptake and mobilization, whereas inhibition of intracellular cholesterol trafficking or the plasma membrane-to-ER cholesterol transporter Aster attenuates inflammatory responses. Scavenger receptor class B type 1 (SR-B1) mediates LPS-induced cholesterol uptake, and its inhibition suppresses TLR4 signaling, receptor recruitment to detergent-resistant membrane domains, and TLR4 endocytosis without altering bulk cellular cholesterol. Instead, SR-B1 inhibition remodels the sphingolipidome and expands the sphingomyelin-associated cholesterol pool, as detected by OlyA, while LPS promotes remodeling of this pool and increases accessible cholesterol detected by D4H. Manipulation of sphingomyelin-cholesterol interactions alters membrane properties and TLR4 trafficking, while stabilization of these complexes suppresses inflammatory activation. In vivo, LPS induces remodeling of sphingomyelin-associated cholesterol in microglia, whereas Alzheimer's disease-related ApoE4/Trem2R47H microglia show impaired cholesterol-pool remodeling and enhanced inflammatory responses. Together, these findings establish sphingolipid-dependent cholesterol accessibility as a key regulatory layer controlling TLR4 organization and microglial inflammatory activation, positioning SR-B1 as an upstream regulator of this lipid-signaling axis.
- Open Access
A single Omicron mutation reshapes ORF3a-driven host-cell remodelling
SARS-CoV-2 ORF3a remodels host membranes, but the structural basis and metabolic consequences of this process remain unclear. Here, we combine complementary imaging approaches to define ORF3a function at nanometric scale, identifying underlying mechanisms, and determining how Omicron variant rewire this activity. ORF3a from the ancestral Wuhan strain disrupts Golgi cisternae, drives the formation of ORF3a dense vesicles, remodels mitochondrial architecture, and promotes lipid droplet expansion. Multi-omics analyses further reveal selective triacylglycerol accumulation linked to DGAT1 upregulation, which we validate pharmacologically through DGAT1 inhibition. In contrast, Omicron ORF3a variant, despite carrying only the Thr223Ile substitution within the beta7-beta8 loop at the bottom of the cytosolic domain, induced a dramatic phenotypic shift: ORF3a localizes to multivesicular bodies, preserves Golgi architecture, and fails to induce lipid accumulation. All together, these results identify ORF3a as a regulator of membrane organization and lipid homeostasis, showing how minimal sequence variation rewires host-cell remodelling.
Open AccessA single Omicron mutation reshapes ORF3a-driven host-cell remodelling
SARS-CoV-2 ORF3a remodels host membranes, but the structural basis and metabolic consequences of this process remain unclear. Here, we combine complementary imaging approaches to define ORF3a function at nanometric scale, identifying underlying mechanisms, and determining how Omicron variant rewire this activity. ORF3a from the ancestral Wuhan strain disrupts Golgi cisternae, drives the formation of ORF3a dense vesicles, remodels mitochondrial architecture, and promotes lipid droplet expansion. Multi-omics analyses further reveal selective triacylglycerol accumulation linked to DGAT1 upregulation, which we validate pharmacologically through DGAT1 inhibition. In contrast, Omicron ORF3a variant, despite carrying only the Thr223Ile substitution within the beta7-beta8 loop at the bottom of the cytosolic domain, induced a dramatic phenotypic shift: ORF3a localizes to multivesicular bodies, preserves Golgi architecture, and fails to induce lipid accumulation. All together, these results identify ORF3a as a regulator of membrane organization and lipid homeostasis, showing how minimal sequence variation rewires host-cell remodelling.
- Open Access
- 28 April 2026
- Published by Springer Nature in Research Square
Circulating lipids uncover early membrane disruption as a primary event preceding Alzheimer’s disease onset
Alzheimer’s disease (AD) is not a single entity but a biologically heterogeneous disorder, with substantial inter-individual variability in clinical presentation, molecular drivers, and disease trajectories. This heterogeneity limits current diagnostic and therapeutic strategies, which largely rely on late-stage protein biomarkers that, while sensitive to prodromal impairment, remain insufficient for primary prevention and patient stratification. Lipids are fundamental to brain structure and function, yet their role in the earliest stages of AD remains poorly defined. Here, we identify a robust, early-life lipid signature in serum from asymptomatic carriers of the PSEN1-E280A mutation, detectable from childhood. Using latent profile analysis, we resolve distinct lipid states associated with risk and resilience to dementia, modulated by genetic status, sex, and APOE genotype, and supported by concordant changes in circulating protein biomarkers. Mechanistically, these lipid alterations point to early and sustained disruptions in cholesterol and sphingolipid metabolism, suggesting that impaired lipid turnover is a primary event in AD pathogenesis rather than a downstream consequence. Our findings position circulating lipids as dynamic reporters of disease-relevant cellular pathways and reveal a previously unrecognized metabolic dimension of the presymptomatic phase of AD. Together, this work reframes AD as a disorder of early metabolic dysregulation and highlights lipidomic profiling as a powerful approach for early detection, risk stratification, and mechanistic insight.
- 28 April 2026
- Published by Springer Nature in Research Square
Open AccessCirculating lipids uncover early membrane disruption as a primary event preceding Alzheimer’s disease onset
Alzheimer’s disease (AD) is not a single entity but a biologically heterogeneous disorder, with substantial inter-individual variability in clinical presentation, molecular drivers, and disease trajectories. This heterogeneity limits current diagnostic and therapeutic strategies, which largely rely on late-stage protein biomarkers that, while sensitive to prodromal impairment, remain insufficient for primary prevention and patient stratification. Lipids are fundamental to brain structure and function, yet their role in the earliest stages of AD remains poorly defined. Here, we identify a robust, early-life lipid signature in serum from asymptomatic carriers of the PSEN1-E280A mutation, detectable from childhood. Using latent profile analysis, we resolve distinct lipid states associated with risk and resilience to dementia, modulated by genetic status, sex, and APOE genotype, and supported by concordant changes in circulating protein biomarkers. Mechanistically, these lipid alterations point to early and sustained disruptions in cholesterol and sphingolipid metabolism, suggesting that impaired lipid turnover is a primary event in AD pathogenesis rather than a downstream consequence. Our findings position circulating lipids as dynamic reporters of disease-relevant cellular pathways and reveal a previously unrecognized metabolic dimension of the presymptomatic phase of AD. Together, this work reframes AD as a disorder of early metabolic dysregulation and highlights lipidomic profiling as a powerful approach for early detection, risk stratification, and mechanistic insight.
- Open Access
- 11 February 2026
- Published by Springer Nature in The EMBO Journal
- Vol. 45 (5) , 1760-1793
STIM1-containing contact sites promote direct calcium flux from the endoplasmic reticulum to mitochondria
STIM1 is a transmembrane protein localized in the endoplasmic reticulum (ER), where it acts as a calcium ion sensor, activating store-operated Ca 2+ entry upon ER Ca 2+ depletion. Via cellular calcium influx, STIM1 is thought to indirectly affect mitochondrial calcium content. Here we show that STIM1 also interacts with mitochondrial proteins such as PTPIP51 and GRP75, suggesting its presence in mitochondria-associated ER membranes (MAMs), which are specialized ER regions that facilitate ER-mitochondria communication. Lowering STIM1 expression disrupts ER-to-mitochondria Ca 2+ transfer, reduces basal mitochondrial Ca 2+ levels, impairs maximal mitochondrial respiration, and reduces ATP production. The STIM1-GRP75 interaction depends on STIM1’s Ca 2+ -sensing ability. ER Ca 2+ depletion or the constitutive-open R429C mutation both reduce STIM1 binding to GRP75, suggesting that conformational changes in STIM1 play a role in this interaction. Deletion analysis revealed that the STIM1 (551-611) segment is crucial for GRP75 binding, as the peptide STIM1(551-611) binds GRP75, while STIM1(Δ551-611) shows reduced binding. These findings reveal a previously unrecognized role of STIM1 in direct inter-organelle communication.
- 11 February 2026
- Published by Springer Nature in The EMBO Journal
- Vol. 45 (5) , 1760-1793
Open AccessSTIM1-containing contact sites promote direct calcium flux from the endoplasmic reticulum to mitochondria
STIM1 is a transmembrane protein localized in the endoplasmic reticulum (ER), where it acts as a calcium ion sensor, activating store-operated Ca 2+ entry upon ER Ca 2+ depletion. Via cellular calcium influx, STIM1 is thought to indirectly affect mitochondrial calcium content. Here we show that STIM1 also interacts with mitochondrial proteins such as PTPIP51 and GRP75, suggesting its presence in mitochondria-associated ER membranes (MAMs), which are specialized ER regions that facilitate ER-mitochondria communication. Lowering STIM1 expression disrupts ER-to-mitochondria Ca 2+ transfer, reduces basal mitochondrial Ca 2+ levels, impairs maximal mitochondrial respiration, and reduces ATP production. The STIM1-GRP75 interaction depends on STIM1’s Ca 2+ -sensing ability. ER Ca 2+ depletion or the constitutive-open R429C mutation both reduce STIM1 binding to GRP75, suggesting that conformational changes in STIM1 play a role in this interaction. Deletion analysis revealed that the STIM1 (551-611) segment is crucial for GRP75 binding, as the peptide STIM1(551-611) binds GRP75, while STIM1(Δ551-611) shows reduced binding. These findings reveal a previously unrecognized role of STIM1 in direct inter-organelle communication.
- Open Access
- 29 January 2025
- Published by SAGE Publications in Contact: The Journal of Inter-Organelle Communication
- Vol. 8
Mitochondria-Associated Endoplasmic Reticulum Membranes in Microglia: One Contact Site to Rule Them all
Microglia, the resident immune cells of the central nervous system (CNS), play a crucial role in maintaining tissue homeostasis by monitoring and responding to environmental changes through processes such as phagocytosis, cytokine production or synapse remodeling. Their dynamic nature and diverse functions are supported by the regulation of multiple metabolic pathways, enabling microglia to efficiently adapt to fluctuating signals. A key aspect of this regulation occurs at mitochondria-associated ER membranes (MAM), specialized contact sites between the ER and mitochondria. These structures facilitate the exchange of calcium, lipids, and metabolites and serve as metabolic and signaling hubs. This review synthesizes current research on how MAM influence microglial physiology, with an emphasis on their role in immunometabolism, offering new insights into the integration of metabolic and immune functions in the CNS and its impact in the context of neurodegeneration.
- 29 January 2025
- Published by SAGE Publications in Contact: The Journal of Inter-Organelle Communication
- Vol. 8
Open AccessMitochondria-Associated Endoplasmic Reticulum Membranes in Microglia: One Contact Site to Rule Them all
Microglia, the resident immune cells of the central nervous system (CNS), play a crucial role in maintaining tissue homeostasis by monitoring and responding to environmental changes through processes such as phagocytosis, cytokine production or synapse remodeling. Their dynamic nature and diverse functions are supported by the regulation of multiple metabolic pathways, enabling microglia to efficiently adapt to fluctuating signals. A key aspect of this regulation occurs at mitochondria-associated ER membranes (MAM), specialized contact sites between the ER and mitochondria. These structures facilitate the exchange of calcium, lipids, and metabolites and serve as metabolic and signaling hubs. This review synthesizes current research on how MAM influence microglial physiology, with an emphasis on their role in immunometabolism, offering new insights into the integration of metabolic and immune functions in the CNS and its impact in the context of neurodegeneration.
- Open Access
- 3 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Altered mitochondria-associated ER membrane (MAM) function shifts mitochondrial metabolism in amyotrophic lateral sclerosis (ALS)
Mitochondrial function is modulated by its interaction with the endoplasmic reticulum (ER). Recent research indicates that these contacts are disrupted in familial models of amyotrophic lateral sclerosis (ALS). We report here that this impairment in the crosstalk between mitochondria and the ER impedes the use of glucose-derived pyruvate as mitochondrial fuel, causing a shift to fatty acids to sustain energy production. Over time, this deficiency alters mitochondrial electron flow and the active/dormant status of complex I in spinal cord tissues, but not in the brain. These findings suggest mitochondria-associated ER membranes (MAM domains) play a crucial role in regulating cellular glucose metabolism and that MAM dysfunction may underlie the bioenergetic deficits observed in ALS.
- 3 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Open AccessAltered mitochondria-associated ER membrane (MAM) function shifts mitochondrial metabolism in amyotrophic lateral sclerosis (ALS)
Mitochondrial function is modulated by its interaction with the endoplasmic reticulum (ER). Recent research indicates that these contacts are disrupted in familial models of amyotrophic lateral sclerosis (ALS). We report here that this impairment in the crosstalk between mitochondria and the ER impedes the use of glucose-derived pyruvate as mitochondrial fuel, causing a shift to fatty acids to sustain energy production. Over time, this deficiency alters mitochondrial electron flow and the active/dormant status of complex I in spinal cord tissues, but not in the brain. These findings suggest mitochondria-associated ER membranes (MAM domains) play a crucial role in regulating cellular glucose metabolism and that MAM dysfunction may underlie the bioenergetic deficits observed in ALS.
- Open Access
The contribution of mitochondria-associated ER membranes to cholesterol homeostasis
Cellular demands for cholesterol are met by a balance between its biosynthesis in the endoplasmic reticulum (ER) and its uptake from lipoproteins. Cholesterol levels in intracellular membranes form a gradient maintained by a complex network of mechanisms including the control of the expression, compartmentalization and allosteric modulation of the enzymes that balance endogenous and exogenous sources of cholesterol. Low-density lipoproteins (LDLs) are internalized and delivered to lysosomal compartments to release their cholesterol content, which is then distributed within cellular membranes. High-density lipoproteins (HDLs), on the other hand, can transfer their cholesterol content directly into cellular membranes through the action of receptors such as the scavenger receptor B type 1 (SR-B1; gene SCARB1 ). We show here that SR-B1-mediated exogenous cholesterol internalization from HDL stimulates the formation of lipid-raft subdomains in the ER known as mitochondria-associated ER membranes (MAM), that, in turn, suppress de novo cholesterol biosynthesis machinery. We propose that MAM is a regulatory hub for cholesterol homeostasis that offers a novel dimension for understanding the intracellular regulation of this important lipid.
Open AccessThe contribution of mitochondria-associated ER membranes to cholesterol homeostasis
Cellular demands for cholesterol are met by a balance between its biosynthesis in the endoplasmic reticulum (ER) and its uptake from lipoproteins. Cholesterol levels in intracellular membranes form a gradient maintained by a complex network of mechanisms including the control of the expression, compartmentalization and allosteric modulation of the enzymes that balance endogenous and exogenous sources of cholesterol. Low-density lipoproteins (LDLs) are internalized and delivered to lysosomal compartments to release their cholesterol content, which is then distributed within cellular membranes. High-density lipoproteins (HDLs), on the other hand, can transfer their cholesterol content directly into cellular membranes through the action of receptors such as the scavenger receptor B type 1 (SR-B1; gene SCARB1 ). We show here that SR-B1-mediated exogenous cholesterol internalization from HDL stimulates the formation of lipid-raft subdomains in the ER known as mitochondria-associated ER membranes (MAM), that, in turn, suppress de novo cholesterol biosynthesis machinery. We propose that MAM is a regulatory hub for cholesterol homeostasis that offers a novel dimension for understanding the intracellular regulation of this important lipid.
- Open Access
Altered MAM function shifts mitochondrial metabolism in SOD1-mutant models of ALS
Mitochondrial defects are a common hallmark of familial and sporadic forms of amyotrophic lateral sclerosis (ALS). However, the origin of these defects, including reduced pyruvate metabolism and reduced oxygen consumption, is poorly understood. These metabolic functions are regulated in specialized endoplasmic reticulum (ER) domains in close contact with mitochondria, called mitochondrial-associated ER membranes (MAM). Recently it has been shown that MAM domains are disrupted in ALS, but the connection between MAM dysregulation and mitochondrial defects in ALS cells remains unclear. Using human embryonic stem cell (ESC)-derived motor neurons (hMNs) and mouse models with ALS-pathogenic mutations in superoxide dismutase 1 (SOD1), we found that the glycolytic deficiency in ALS is a direct consequence of the progressive disruption of MAM structure and function that hinders the use of glucose-derived pyruvate as a mitochondrial fuel and triggers a shift in mitochondrial substrates from pyruvate to fatty acids. This glycolytic deficiency, over time, induces significant alterations in mitochondrial electron flow and in the active/dormant (A/D) status of complex I in spinal cord, but not in brain. These data agree with a role for MAM in the maintenance and regulation of cellular glucose metabolism and suggest that MAM disruption in ALS could be the underlying cause of the bioenergetic deficits observed in the disease.
Open AccessAltered MAM function shifts mitochondrial metabolism in SOD1-mutant models of ALS
Mitochondrial defects are a common hallmark of familial and sporadic forms of amyotrophic lateral sclerosis (ALS). However, the origin of these defects, including reduced pyruvate metabolism and reduced oxygen consumption, is poorly understood. These metabolic functions are regulated in specialized endoplasmic reticulum (ER) domains in close contact with mitochondria, called mitochondrial-associated ER membranes (MAM). Recently it has been shown that MAM domains are disrupted in ALS, but the connection between MAM dysregulation and mitochondrial defects in ALS cells remains unclear. Using human embryonic stem cell (ESC)-derived motor neurons (hMNs) and mouse models with ALS-pathogenic mutations in superoxide dismutase 1 (SOD1), we found that the glycolytic deficiency in ALS is a direct consequence of the progressive disruption of MAM structure and function that hinders the use of glucose-derived pyruvate as a mitochondrial fuel and triggers a shift in mitochondrial substrates from pyruvate to fatty acids. This glycolytic deficiency, over time, induces significant alterations in mitochondrial electron flow and in the active/dormant (A/D) status of complex I in spinal cord, but not in brain. These data agree with a role for MAM in the maintenance and regulation of cellular glucose metabolism and suggest that MAM disruption in ALS could be the underlying cause of the bioenergetic deficits observed in the disease.